Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Peter Heseltine, Mark Emberton

Premium

Singulex has appointed Peter Heseltine as chief medical officer.

Heseltine is professor of Clinical Medicine at the University of California, Irvine. Previously he was senior vice president and chief medical officer at Prometheus Laboratories. He also held executive positions at Beckman Coulter and Quest Diagnostics.


ProteoMedix has named Mark Emberton as a clinical advisor.

Emberton is director of the Division of Surgery and Interventional Science at University College, London as well as a founding partner of London Urology Associates.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.